Company Badge
USPTO Data Jan 1 1976 - Oct 13 2026
5 Patents
#21 in Aarhus
#471 in Denmark
Action Pharma A/s
Forward Citations = 43
12 inventors:
Action Pharma A/s
% Expired Patents = 60.0
EPO Patents = 1
Forward Citations = 43
Loading Chart...
Loading Chart...
12 inventors (with patents filed for the assignee):
Torbjörn Lundstedt (3 out of 10 patents)
Arne Boman (3 out of 6 patents)
Jarl Wikberg (2 out of 4 patents)
4. Elisabeth Seifert (2 out of 8 patents)
5. Michael Szardenings (2 out of 5 patents)
6. Anna Skottner (2 out of 12 patents)
7. Victor Andrianov (2 out of 10 patents)
8. Ruta Muceniece (2 out of 2 patents)
9. Ilze Mutule (2 out of 2 patents)
10. Felikss Mutulis (2 out of 2 patents)
11. Per Andersson (2 out of 3 patents)
12. Thomas Engelbrecht Norkild Jonassen (1 out of 1 patent)
5 patents:
Company Overview
Action Pharma A/S is a pharmaceutical company specializing in the development of innovative treatments for rare and genetic diseases. With a focus on precision medicine, the company aims to improve patient outcomes and quality of life. Their pipeline includes promising candidates for conditions such as lysosomal storage disorders and rare neurological diseases. Action Pharma is committed to advancing research and bringing novel therapies to market to address unmet medical needs.
Profile summary synthesized from public USPTO records and patent filings.
IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Action Pharma A/s. Retrieved from https://idiyas.com/company/action-pharma-a-s
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
1 patent (EPO):
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]